SOLID BIOSCIENCES INC (SLDB) — insider trading
Health Care · NASDAQ
SOLID BIOSCIENCES INC (SLDB) has 21 reported SEC Form 4 insider transactions in our data (latest 2026-10-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | SMITH IAN F | Director | Option exercise / conversion (derivative) | 3,440 | — | $0 | Form 4 |
| 2026-10-02 | SMITH IAN F | Director | Option exercise / conversion | 3,440 | — | — | Form 4 |
| 2026-07-02 | SMITH IAN F | Director | Option exercise / conversion (derivative) | 3,440 | — | $0 | Form 4 |
| 2026-07-02 | SMITH IAN F | Director | Option exercise / conversion | 3,440 | — | — | Form 4 |
| 2026-06-10 | Stone Adam Leo | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Sullivan Lynne Marie | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Kahn Clare | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Freed Martin I | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Keresty Georgia | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | PERCEPTIVE ADVISORS LLC; EDELMAN JOSEPH; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | Director, 10% owner | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Ganot Ilan | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | SMITH IAN F | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-06-10 | Nagendran Sukumar | Director | Grant / award / vesting (derivative) | 77,500 | — | $0 | Form 4 |
| 2026-04-02 | SMITH IAN F | Director | Option exercise / conversion (derivative) | 3,441 | — | $0 | Form 4 |
| 2026-04-02 | SMITH IAN F | Director | Option exercise / conversion | 3,441 | — | — | Form 4 |
| 2026-01-29 | Hanrahan Jessie | Officer (Chief Regulatory Officer) | Grant / award / vesting (derivative) | 54,925 | — | $0 | Form 4 |
| 2026-01-29 | Tan Kevin | Officer (CFO & Treasurer) | Grant / award / vesting (derivative) | 56,647 | — | $0 | Form 4 |
| 2026-01-29 | Herzich Paul | Officer (Chief Technology Officer) | Grant / award / vesting (derivative) | 54,925 | — | $0 | Form 4 |
| 2026-01-29 | Cumbo Alexander | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 169,401 | — | $0 | Form 4 |
| 2026-01-29 | Brooks Gabriel | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 58,847 | — | $0 | Form 4 |
| 2026-01-29 | Howton David T | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 79,341 | — | $0 | Form 4 |
Ask the chat about SLDB's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SOLID BIOSCIENCES INC (SLDB).
Last updated 2026-10-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.